Perceptive Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Perceptive Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-714	Closed	-$260K	–	165
2017 Q4	$260K	Hold	714	–	–	0.01%	128
2017 Q3	$412K	Hold	714	–	–	0.02%	130
2017 Q2	$705K	Hold	714	–	–	0.04%	104
2017 Q1	$950K	Buy	+714	New	+$862K	0.05%	97

Other funds holding ZSAN

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Iguana Healthcare Management New York $133M AUM 48.74% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return